<SEC-DOCUMENT>0001144204-15-047813.txt : 20150910
<SEC-HEADER>0001144204-15-047813.hdr.sgml : 20150910
<ACCEPTANCE-DATETIME>20150810165850
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001144204-15-047813
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20150810

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIO BLAST PHARMA LTD.
		CENTRAL INDEX KEY:			0001596812
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		37 DEREH MENACHEM BEGIN ST.
		STREET 2:		15TH FLOOR
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6522042
		BUSINESS PHONE:		972 (0) 3 7326616

	MAIL ADDRESS:	
		STREET 1:		37 DEREH MENACHEM BEGIN ST.
		STREET 2:		15TH FLOOR
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6522042
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;<IMG SRC="image_001.jpg" ALT=""></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#9;&#9;August 10, 2015</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Via EDGAR</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">United States Securities and Exchange Commission</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Division of Corporation Finance</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">100 F Street NE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Washington, DC 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attn: Jeffrey P. Riedler, Division of Corporate Finance</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt">RE:</TD>
    <TD STYLE="width: 91%; padding-right: 5.4pt; padding-left: 5.4pt"><B>Bio Blast Pharma Ltd.</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><B>Registration Statement on Form F-3 </B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><B>Filed on August 3, 2015 </B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><B>File No. 333-206032</B></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Bio Blast Pharma Ltd. (&ldquo;<U>BioBlast</U>&rdquo;)
hereby requests acceleration of the effectiveness of the above-referenced registration statement pursuant to Rule 460 and Rule
461 under the Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), so that it may become effective on
August 12, 2015, at 4:30 p.m., Eastern Time, or as soon thereafter as is practicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">BioBlast acknowledges that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>should the Commission or the staff, acting pursuant to delegated authority, declare the above-referenced registration statement
effective, it does not foreclose the Commission from taking any action with respect to the above-referenced registration statement;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the above-referenced registration
statement effective, does not relieve BioBlast from its full responsibility for the adequacy and accuracy of the disclosure in
the above-referenced registration statement; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>BioBlast may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the
Commission or any person under the federal securities laws of the United States.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities and Exchange Commission</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">August 10, 2015</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page 2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">BioBlast understands that the Commission
will consider this request for acceleration of the effective date of this above-referenced registration statement as a confirmation
of the fact that BioBlast is aware of its respective responsibilities under the Securities Act and the Securities Exchange Act
of 1934, as amended, as they relate to the proposed public offering of the securities specified in the referenced above registration
statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding: 0">&nbsp;</TD>
    <TD STYLE="width: 50%; padding: 0">Very truly yours,</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0">&nbsp;</TD>
    <TD STYLE="padding: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0">&nbsp;</TD>
    <TD STYLE="padding: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-decoration: underline"><U>/s/ Colin Foster</U></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0">&nbsp;</TD>
    <TD STYLE="padding: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0">&nbsp;</TD>
    <TD STYLE="padding: 0">Colin Foster</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0">&nbsp;</TD>
    <TD STYLE="padding: 0">Chief Executive Officer and President</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Cc: &#9;Shy S. Baranov, Esq.</P>



<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !" 38# 2(  A$! Q$!_\0
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MO)S_ "JM8?!/PQI@C.H:O=7EU_RTM?)VH/HW>OT9N-%L+J-(YK*"1$X56C!
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M]\@_NLP!(_"OJSP#O:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Y;XA:59
M7GAJ^EGL[>:54X>2)6(_$BO@#XB0I%K!5$5!SPHQWHHH ^G_ -E'2[.33;F=
MK2!IT52LC1J67IT..*^B:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
H@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
